Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Trinity Biotech Invt Ltd (TRIB)

19 + Investors. Track Smart Money conviction in TRIB. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -6
Streak
3Q ▼
Buyers last Q
39%

Smart Money Signals — TRIB

Based on 19 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds reduced or closed their TRIB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 63% of 3.0Y high

63% of all-time peak
Only 19 funds hold TRIB today versus a peak of 30 funds at 2025 Q3 — just 63% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 27% fewer funds vs a year ago

fund count last 6Q
7 fewer hedge funds hold TRIB compared to a year ago (-27% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🔴

Heavy selling pressure — only 39% buying

7 buying11 selling
Last quarter: 11 funds sold vs only 7 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.
➡️

Steady new buyers — ~1 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 8 → 4 → 5 → 1. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

79% of holders stayed for 2+ years

79% conviction (2yr+) 21% medium 0% new
15 out of 19 hedge funds have held TRIB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -5%, value -51%

Value
-51%
Shares
-5%
Last quarter: funds added -5% more shares while total portfolio value only changed -51%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
⚠️

Saturation — most institutions already know this story

4 → 8 → 4 → 5 → 1 new funds/Q
New funds entering each quarter: 8 → 4 → 5 → 1. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🏛️

Veteran-anchored — 80% veterans vs 0% newcomers

80% veterans 20% 1-2yr 0% new
Entry-cohort mix of 20 holders: 16 (80%) are 2+ year veterans, 4 entered 1–2 years ago, and 0 (0%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds
8 of 19 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
1.7
out of 10
Low Exit Risk
Exit risk score 1.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TRIB

In 2026 Q2, 7 hedge funds were net buyers of TRIB (1 opened a new position, 6 added to an existing one), while 11 reduced or exited (4 trimmed, 7 sold completely) — a 39% buyer ratio, indicating net institutional distribution. This extends a 3-quarter selling streak, suggesting sustained institutional caution. Net fund flow last quarter: -6 funds (more exits than new entries). Total institutional holders: 19.

Hedge Fund Ownership: TRIB

How many hedge funds hold TRIB — quarterly history vs. share price
Quarterly hedge fund ownership of TRIB vs. share price

Market Analysis: TRIB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TRIB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Trinity Biotech Invt Ltd (TRIB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TRIB has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 78d ago
TRIB
-36.2%
XLV
+5.7%

TRIB outperformed XLV by -41.9% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 33d ago
TRIB
-36.0%
XLV
+0.2%

Since the filing became public, TRIB outperformed XLV by -36.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

1 top-rated funds 0 high-conviction
Consensus
1.3
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: TRIB
19 + Investors

Track Smart Money conviction in TRIB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 19 25 -24.0%
13F Shares 1M 1M -5.34%
Total Value $139K $287K -51.47%
New Positions 1 5 -4
Increased Positions 6 4 +2
Closed Positions 7 9 -2
Reduced Positions 4 5 -1
Total Calls 1 2 -50.0%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: TRIB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

19 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TRIB. Verified SEC 13F-HR filings.

QUARTER:
Top 17 TRIB holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Williams & Novak Wealth Management, LLC 0.04% 140,543 $55K
2 Inspirion Wealth Advisors, LLC 0.00% 25,000 $9K
3 Moss Adams Wealth Advisors LLC 0.00% 25,666 $10K
4 Becker Capital Management Inc 0.00% 18,000 $7K
5 Farther Finance Advisors, LLC 0.00% 2,000
6 Rhumbline Advisers 0.00% 9,369 $4K
7 Raymond James Financial Inc 0.00% 20,319 $8K
8 Osaic Holdings, INC. 0.00% 3,500 $1K
9 LPL Financial LLC 0.00% 17,668 $7K
10 Susquehanna International Group, LLP 0.00% 49,700 $19K
11 Susquehanna International Group, LLP 0.00% 26,859 $10K
12 Jones Financial Companies Lllp 0.00% 3,644 $1K
13 Atwood & Palmer Inc 0.00% 20
14 Wells Fargo & Company/Mn 0.00% 2,500
15 Simplex Trading, LLC 0.00% 354
16 UBS Group AG 0.00% 1,107
17 Morgan Stanley 0.00% 400
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Trinity Biotech Invt Ltd (TRIB)

What does the Smart Money Trend signal show for TRIB?

Selling streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds reduced or closed their TRIB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for TRIB?

Heavy selling pressure — only 39% buying: Last quarter: 11 funds sold vs only 7 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for TRIB holders?

Smaller funds dominant — 15% AUM from top-100: 8 of 19 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held TRIB?

79% of holders stayed for 2+ years: 15 out of 19 hedge funds have held TRIB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Trinity Biotech Invt Ltd (TRIB) following the 2026 Q2 hedge fund 13F filings?

As of today, TRIB has moved -36.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.2% for the XLV sector ETF — an outperformance of -36.2%. Since the quarter end (June 30, 2026), TRIB has gained -36.2% vs +5.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →